According to FutureWise analysis, the diabetes diagnostics market in 2026 is US$ 39.2 billion, and is expected to reach US$84.7 billion by 2036 at a CAGR of 8.00%.
This growth is driven by the rising global prevalence of diabetes and increasing demand for early and accurate diagnosis. Advancements in continuous glucose monitoring (CGM) systems and digital health integration are significantly improving patient outcomes and adoption rates. Growing awareness regarding preventive healthcare and routine blood glucose monitoring is further supporting market expansion. Additionally, the shift toward home-based and wearable diagnostic devices is transforming diabetes management, making it more convenient and real-time.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Diabetes Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Diabetes Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.